Your browser does not support JavaScript
For Practitioners
 

Practitioners





   uriROX-1   BOTH   uriROX-2


    • May or may not have had a kidney stone in the past 2 years
    • Expected to last about 12 weeks
    • If you are interested in learning more about uriROX-1
    , click here


Looking for
people with enteric hyperoxaluria 

    • Specifically looking for people that have had a kidney stone(s) in the past 2 years
    • Expected to last a minimum of 2 years and may last up to a maximum of 5 years
    • If you are interested in learning more about uriROX-2, click here


Select your study


Has your patient had a history of hyperoxaluria (HOx) due to an underlying malabsorptive gastrointestional condition (e.g., bariatric surgery, Crohn’s disease, short bowel syndrome, or other malabsorption disorders)?

If YES, your patient may be eligible for 1 of 2 clinical research studies.

uriROX-1 uriROX-1
 
uriROX-2 uriROX-2
 
  PRIVACY POLICY | TERMS OF USE
© 2019 Allena Pharmaceuticals, Inc. All rights reserved.